|
CLDND1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.68039948412036E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.0877999945258E-08 |
| Normal-vs-Stage2 |
8.59590176816027E-11 |
| Normal-vs-Stage3 |
3.54809515101806E-11 |
| Normal-vs-Stage4 |
1.02969999193903E-09 |
| Stage1-vs-Stage2 |
7.395500E-03 |
| Stage1-vs-Stage3 |
4.423100E-03 |
| Stage1-vs-Stage4 |
1.401800E-01 |
| Stage2-vs-Stage3 |
6.297200E-01 |
| Stage2-vs-Stage4 |
2.808000E-01 |
| Stage3-vs-Stage4 |
4.962400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.98169949736393E-10 |
| Normal-vs-AfricanAmerican |
1.55500999999836E-05 |
| Normal-vs-Asian |
4.84810000001001E-06 |
| Caucasian-vs-AfricanAmerican |
4.870000E-01 |
| Caucasian-vs-Asian |
5.106000E-02 |
| AfricanAmerican-vs-Asian |
5.162800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.99249966420712E-10 |
| Normal-vs-Female |
9.63029989087261E-10 |
| Male-vs-Female |
4.226400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.59379999975506E-07 |
| Normal-vs-Age(41-60Yrs) |
8.5773055324978E-11 |
| Normal-vs-Age(61-80Yrs) |
4.26259028074583E-12 |
| Normal-vs-Age(81-100Yrs) |
1.190090E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.225700E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.67650000000497E-05 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.456600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.481630E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.583600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.081200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.097800E-02 |
| Classical-VS-Follicular |
3.953600E-04 |
| Classical-VS-Other |
5.024000E-01 |
| Classical-VS-Normal |
5.24259999856724E-08 |
| Tall-VS-Follicular |
7.956800E-01 |
| Tall-VS-Other |
6.974000E-01 |
| Tall-VS-Normal |
1.98049998623162E-09 |
| Follicular-VS-Other |
6.201400E-01 |
| Follicular-VS-Normal |
4.71389594025595E-11 |
| Other-VS-Normal |
7.279000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.67139643739256E-11 |
| Normal-vs-N1 |
1.24509999976929E-07 |
| N0-vs-N1 |
8.022100E-02 |
|
|
